AWD131-138isapositiveallostericmodulatorofGABA-Areceptors;itactsatthebenzodiazepinesite.AWD131-138isusedinveterinarymedicinetotreatcanineepilepsyasitdisplaysanticonvulsantandantiepilepticactivities.Invariousanimalmodels,thiscompoundpreventsconvulsionsandthedevelopmentofepilepsyandincreasesseizurethresholds.
| CasNo. | 188116-07-6 |
|---|---|
| Purity | ≥99% |
| Formula | C13H14ClN3O2 |
| FormulaWt. | 279.72 |
| IUPACName | 1-(4-Chlorophenyl)-4-(4-morpholinyl)-1,5-dihydro-2H-imidazol-2-one |
| StoreTemp | -20°C |
|---|---|
| ShipTemp | Ambient |
| InfoSheet | A8812InfoSheetPDF |
|---|
RundfeldtC,LöscherW.Thepharmacologyofimepitoin:thefirstpartialbenzodiazepinereceptoragoNISTdevelopedforthetreatmentofepilepsy.CNSDrugs.2014Jan;28(1):29-43.PMID:24357084.
LöscherW,HoffmannK,TweleF,etal.ThenovelantiepilepticdrugimepitoincomparesfavourablytootherGABA-mimeticdrugsinaseizurethresholdmodelinmiceanddogs.PharmacolRes.2013Nov;77:39-46.PMID:24056205.
YasarS,BergmanJ,MunzarP,etal.Evaluationofthenovelantiepilepticdrug,AWD131-138,forbenzodiazepine-likediscriminativestimulusandreinforcingeffectsinsquirrelmonkeys.EurJPharmacol.2003Apr4;465(3):257-65.PMID:12681437.
